Real-World Primary Care Data Comparing ALT and FIB-4 in Predicting Future Severe Liver Disease Outcomes.
Andrew D SchreinerJingwen ZhangWilliam P MoranDavid G KochSherry LivingstonChloe BaysJustin MarsdenPatrick D MauldinMulugeta GebregziabherPublished in: Journal of general internal medicine (2023)
High-risk FIB-4 scores demonstrated superior performance compared to abnormal ALT in predicting future SLD outcomes.